天域生物科技股份有限公司关于2025年半年度业绩说明会召开情况的公告

Core Viewpoint - The company held a half-year performance briefing on September 10, 2025, to discuss its operational performance and future growth drivers with investors [1][2]. Group 1: Meeting Details - The performance briefing was attended by key executives including the Chairman and acting CEO, independent directors, and the CFO, who engaged with investors on various concerns [2]. - The meeting was conducted via an online interactive platform, allowing for direct communication between the company and investors [1]. Group 2: Investor Questions and Company Responses - The company identified key drivers for future profit growth, including the efficiency of accounts receivable collection, sales in the pig market, cost control, and the advancement of smart agriculture initiatives [3]. - The company highlighted its technological advantages in the current market, mentioning the establishment of a core breeding base in Hubei Province and collaboration with Huazhong Agricultural University for genetic breeding research, which aims to enhance breeding efficiency and reduce costs [3]. - Regarding future dividend plans, the company referred investors to a previously released announcement detailing its shareholder return plan for 2025-2027 [3].